vs
Side-by-side financial comparison of Netcapital Inc. (NCPL) and PureTech Health plc (PRTC). Click either name above to swap in a different company.
PureTech Health plc is the larger business by last-quarter revenue ($180.0K vs $94.3K, roughly 1.9× Netcapital Inc.). Netcapital Inc. runs the higher net margin — -1921.5% vs -22820.6%, a 20899.1% gap on every dollar of revenue.
Netcapital Inc. runs a U.S.-focused digital private capital markets platform that connects growth-seeking early startups, small and medium private businesses with accredited and non-accredited individual investors, providing fundraising support for issuers and accessible alternative investment options for platform users.
PureTech Health plcPRTCEarnings & Financial Report
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
NCPL vs PRTC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $94.3K | $180.0K |
| Net Profit | $-1.8M | $-41.1M |
| Gross Margin | 98.1% | — |
| Operating Margin | -2304.6% | -38908.9% |
| Net Margin | -1921.5% | -22820.6% |
| Revenue YoY | -38.2% | — |
| Net Profit YoY | 39.7% | — |
| EPS (diluted) | $-0.32 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $94.3K | — | ||
| Q4 25 | $51.1K | — | ||
| Q3 25 | $190.1K | — | ||
| Q2 25 | $404.0K | — | ||
| Q1 25 | $152.7K | — | ||
| Q4 24 | $170.5K | — | ||
| Q3 24 | $142.2K | — | ||
| Q2 24 | $347.2K | — |
| Q1 26 | $-1.8M | — | ||
| Q4 25 | $-2.1M | — | ||
| Q3 25 | $-3.6M | — | ||
| Q2 25 | $-20.5M | — | ||
| Q1 25 | $-3.0M | — | ||
| Q4 24 | $-2.2M | — | ||
| Q3 24 | $-2.5M | — | ||
| Q2 24 | — | — |
| Q1 26 | 98.1% | — | ||
| Q4 25 | 96.3% | — | ||
| Q3 25 | 96.1% | — | ||
| Q2 25 | 99.2% | — | ||
| Q1 25 | 95.3% | — | ||
| Q4 24 | 88.4% | — | ||
| Q3 24 | 92.8% | — | ||
| Q2 24 | 96.8% | — |
| Q1 26 | -2304.6% | — | ||
| Q4 25 | -4149.6% | — | ||
| Q3 25 | -1728.8% | — | ||
| Q2 25 | -476.0% | — | ||
| Q1 25 | -1105.4% | — | ||
| Q4 24 | -1291.5% | — | ||
| Q3 24 | -1763.5% | — | ||
| Q2 24 | — | — |
| Q1 26 | -1921.5% | — | ||
| Q4 25 | -4169.3% | — | ||
| Q3 25 | -1916.3% | — | ||
| Q2 25 | -5085.6% | — | ||
| Q1 25 | -1969.1% | — | ||
| Q4 24 | -1302.1% | — | ||
| Q3 24 | -1776.9% | — | ||
| Q2 24 | — | — |
| Q1 26 | $-0.32 | — | ||
| Q4 25 | $-0.44 | — | ||
| Q3 25 | $-1.27 | — | ||
| Q2 25 | $-11.38 | — | ||
| Q1 25 | $-1.57 | — | ||
| Q4 24 | $-2.34 | — | ||
| Q3 24 | $-5.10 | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $191.1M |
| Total DebtLower is stronger | $492.4K | $0 |
| Stockholders' EquityBook value | $21.6M | $458.2M |
| Total Assets | $26.1M | $694.0M |
| Debt / EquityLower = less leverage | 0.02× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $492.4K | — | ||
| Q4 25 | $495.8K | — | ||
| Q3 25 | $500.0K | — | ||
| Q2 25 | $500.0K | — | ||
| Q1 25 | $500.0K | — | ||
| Q4 24 | $500.0K | — | ||
| Q3 24 | $500.0K | — | ||
| Q2 24 | $500.0K | — |
| Q1 26 | $21.6M | — | ||
| Q4 25 | $21.4M | — | ||
| Q3 25 | $23.1M | — | ||
| Q2 25 | $14.9M | — | ||
| Q1 25 | $35.0M | — | ||
| Q4 24 | $37.4M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | $37.9M | — |
| Q1 26 | $26.1M | — | ||
| Q4 25 | $25.4M | — | ||
| Q3 25 | $28.4M | — | ||
| Q2 25 | $20.9M | — | ||
| Q1 25 | $39.9M | — | ||
| Q4 24 | $41.9M | — | ||
| Q3 24 | $41.4M | — | ||
| Q2 24 | $41.6M | — |
| Q1 26 | 0.02× | — | ||
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-868.7K | $-40.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-868.7K | — | ||
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $-5.3M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $-2.0M | — | ||
| Q2 24 | $-4.9M | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
